 | Iterum Therapeutics plc | |||
| NCM : ITRM || Location: Ireland | ||||
$1.430.0 (0.0%) |
0.06 M | 1.42 - 1.51 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 1.225 M |
| March 15, 2024 | 1.208 M |
| Feb. 29, 2024 | 0.975 M |
| Feb. 15, 2024 | 1.166 M |
| Jan. 31, 2024 | 0.052 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.95 | -0.94 | 1.44% |
| 09/30/2023 | -0.93 | -0.30 | 67.68% |
| 06/30/2023 | -1.22 | -0.95 | 22.39% |
| 12/31/2022 | -1.22 | -0.41 | 66.50% |
| 09/30/2022 | -1.07 | -0.97 | 9.43% |
ITRM Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 16.427M | Shares Float | 15.336M |
| Short Float | 1.225M | Market Cap | 23.49M |
| Institution ownership | 7.56% | Insider ownership | 1.516% |
| Earnings Date | 05/10/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.96 | Forward EPS | -1.03 |